logo
New road plans to be examined at public enquiry

New road plans to be examined at public enquiry

Yahoo07-06-2025

A public inquiry is to be held into plans to build the North Hykeham relief road near Lincoln.
The new road would link the A46 with the Lincoln Eastern Bypass, completing the ring road network around the city.
At the enquiry, proposals will be put before an independent planning inspector who will hear evidence before deciding if Lincolnshire County Council can purchase land and gain access to other sites. Those objecting to having their land used or purchased will have the opportunity to put forward arguments.
The inquiry starts on 1 July at the DoubleTree by Hilton hotel in Lincoln and is due to last two weeks.
Objections to the new road have been received from agricultural landowners, businesses and statutory bodies, according to the council.
Councillor Michael Cheyne, executive member for highways, said: "Despite an inquiry being required, we are continuing to progress with the scheme with the intention of starting construction works later this year.
"This scheme is essential to supporting the growth of the area and keeping the county moving, so I look forward to seeing work commence soon."
According to the Local Democracy Reporting Service, the majority of funding towards the project has yet to be confirmed.
The new Reform UK administration has confirmed that it will keep the county council's commitment to providing the remaining £90m.
If construction starts on time, the road is expected to be opened by late 2028.
Listen to highlights from Lincolnshire on BBC Sounds, watch the latest episode of Look North or tell us about a story you think we should be covering here.
Land purchase agreed for last section of ring road
Final section of city ring-road wins approval
Final stretch of bypass recommended for approval
Local Democracy Reporting Service

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Doctor Care Anywhere Group PLC's (ASX:DOC) Path To Profitability
Doctor Care Anywhere Group PLC's (ASX:DOC) Path To Profitability

Yahoo

time30 minutes ago

  • Yahoo

Doctor Care Anywhere Group PLC's (ASX:DOC) Path To Profitability

With the business potentially at an important milestone, we thought we'd take a closer look at Doctor Care Anywhere Group PLC's () future prospects. Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom and the Republic of Ireland. The AU$38m market-cap company announced a latest loss of UK£5.1m on 31 December 2024 for its most recent financial year result. As path to profitability is the topic on Doctor Care Anywhere Group's investors mind, we've decided to gauge market sentiment. In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. Expectations from some of the Australian Healthcare Services analysts is that Doctor Care Anywhere Group is on the verge of breakeven. They expect the company to post a final loss in 2025, before turning a profit of UK£100k in 2026. Therefore, the company is expected to breakeven just over a year from now. What rate will the company have to grow year-on-year in order to breakeven on this date? Using a line of best fit, we calculated an average annual growth rate of 105%, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict. Given this is a high-level overview, we won't go into details of Doctor Care Anywhere Group's upcoming projects, but, bear in mind that generally healthcare tech companies, depending on the stage of product development, have irregular periods of cash flow. This means, large upcoming growth rates are not abnormal as the company is beginning to reap the benefits of earlier investments. View our latest analysis for Doctor Care Anywhere Group One thing we would like to bring into light with Doctor Care Anywhere Group is it currently has negative equity on its balance sheet. Accounting methods used to deal with losses accumulated over time can cause this to occur. This is because liabilities are carried forward into the future until it cancels. These losses tend to occur only on paper, however, in other cases it can be forewarning. There are too many aspects of Doctor Care Anywhere Group to cover in one brief article, but the key fundamentals for the company can all be found in one place – Doctor Care Anywhere Group's company page on Simply Wall St. We've also put together a list of pertinent aspects you should look at: Valuation: What is Doctor Care Anywhere Group worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Doctor Care Anywhere Group is currently mispriced by the market. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Doctor Care Anywhere Group's board and the CEO's background. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here. — Investing narratives with Fair Values A case for TSXV:USA to reach USD $5.00 - $9.00 (CAD $7.30–$12.29) by 2029. By Agricola – Community Contributor Fair Value Estimated: CA$12.29 · 0.9% Overvalued DLocal's Future Growth Fueled by 35% Revenue and Profit Margin Boosts By WynnLevi – Community Contributor Fair Value Estimated: $195.39 · 0.9% Overvalued Historically Cheap, but the Margin of Safety Is Still Thin By Mandelman – Community Contributor Fair Value Estimated: SEK232.58 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Informa TechTarget, Salesloft Partner to Accelerate Revenue with Data-Driven Prospecting
Informa TechTarget, Salesloft Partner to Accelerate Revenue with Data-Driven Prospecting

Yahoo

timean hour ago

  • Yahoo

Informa TechTarget, Salesloft Partner to Accelerate Revenue with Data-Driven Prospecting

TechTarget Inc. (NASDAQ:TTGT) is one of the best IT stocks to buy according to analysts. On June 23, Informa TechTarget announced a partnership and integration with Salesloft, which is a Revenue Orchestration Platform. The collaboration aims to help mutual customers grow revenue by enabling precise and data-driven prospecting, as well as efficiently engaging prospects who are actively in a buying journey. The core of this integration is to streamline workflows between Informa TechTarget's Priority Engine intent data platform and Salesloft's engagement capabilities. Priority Engine provides insights into actively researching buyers and buying groups by using its trusted editorial communities, which include 220+ highly targeted technology-specific websites and over 50 million permissioned first-party audience members. A woman in a virtual conference room speaking to a global audience on a webcast. The integration allows sales teams to easily and automatically push 'Active Prospects' from Priority Engine directly into relevant and topically aligned Salesloft cadences every week, thereby reducing the time between identifying intent signals and initiating sales outreach. By delivering active and permissioned contacts into Salesloft cadences, the integration helps sellers engage the right people with the right message at the right time. TechTarget Inc. (NASDAQ:TTGT) provides purchase intent-driven marketing and advertising campaigns in North America, the UK, and internationally. While we acknowledge the potential of TTGT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store